Nutrimedica, a Nutritional Distributor in Greece, to Purchase an Aggregate
of Over $200,000 of Resurgex(R) in 2008
BASKING RIDGE, N.J., April 1, 2008 /PRNewswire/ -- Millennium Biotechnologies, Inc., a wholly owned subsidiary of Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG), today reports the receipt of a $200,000 one year purchase order for the international distribution of the Resurgex(R) line in Greece. Millennium received the purchase order from Nutrimedica which is headquartered in Athens, Greece. Nutrimedica has served as Millennium's International Distribution Partner into Greece for the past two years. They have committed to purchase over $200,000 of Resurgex products for distribution into Greece in 2008.
This commitment to purchase over $200,000 of Resurgex(R) products for the Greek Market supported by a year to date purchase rate further enhances news released by Millennium in January of 2008 which reported overall sales in the Greek Market has increased from $30,000 in 2006 to $50,000 in 2007. These sales will now exceed $200,000 for 2008 which adds to the further expansion of Resurgex(R) product line into the international marketplace.
Nutrimedica has already imported and distributed Resurgex(R) products to hospitals, pharmacies, and direct to patients in Greece. Nutrimedica reports that the continued use of the Resurgex product line in Greece supports and encourages their expectation that the product line will be successful in the international marketplace.
Nutrimedica has been successful in broadening the usage of the Resurgex product line beyond Oncology, into other hospital settings including Intensive Care Units and Surgery Clinics.
Millennium's six marketed products form the Company's advanced line of
nutritional formulas. Resurgex Select(R) is a whole foods-based,
calorically dense, high-protein nutritional formula developed for cancer
|SOURCE Millennium Biotechnologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved